Inflammatory mechanisms contribute to microembolism-induced anxiety-like and depressive-like behaviors

Keyphrases

• Anxiety-like Behavior 100%
• Microemboli 100%
• Depressive-like Behavior 100%
• Inflammatory Mechanisms 100%
• Ischemia 66%
• Brain Injury 66%
• Behavior Change 66%
• Inflammatory Process 66%
• Meloxicam 66%
• Inflammation 33%
• Risk Factors 33%
• Depressive Symptoms 33%
• Inflammatory Cytokines 33%
• Therapeutic Strategies 33%
• Selective Serotonin Reuptake Inhibitors 33%
• Dysregulation 33%
• Hippocampus 33%
• Effective Treatment 33%
• Biological Systems 33%
• Cardiac Surgery 33%
• Infarct 33%
• Rodent Models 33%
• Inflammatory Genes 33%
• Chronic Inflammation 33%
• Fluoxetine 33%
• Clinically Silent 33%
• Prophylactic Administration 33%
• Embolism 33%
• Linchpin 33%
• Invasive Cardiac Procedures 33%
• Vascular Depression 33%
• Sickness Syndrome 33%
• Sickness Behavior 33%
• COX-2 Activity 33%
• Cerebral Inflammation 33%
• Central Inflammation 33%
• Elevated Levels 33%
• Vascular Health 33%
• Ischemic Episodes 33%
• Contralateral Side 33%
• Anti-inflammatory Treatment 33%

Neuroscience

• Behavior (Neuroscience) 100%
• Brain Injury 40%
• Cardiac Procedures 40%
• Ischemia 40%
• Meloxicam 40%
• Hippocampus 20%
• Selective Serotonin Reuptake Inhibitor 20%
• Microsphere 20%
• Anti-Inflammatory 20%
• Fluoxetine 20%
• Sickness Behavior 20%
• Risk Factor 20%
• Cytokine 20%